Am J Transplant, Volume 21, Suppl 3 Archives - Page 53 of 139 - ATC Abstracts

2021 American Transplant Congress
Efficacy and Safety of a High Dose Ganciclovir Dosing Strategy in Kidney and Pancreas Transplant Recipients
M. Jorgenson¹, J. Descourouez¹, G. Leverson², C. Saddler², J. Smith², D. Mandelbrot², J. Odorico²
¹UW Health, Madison, WI, ²UW School of Medicine and Public Health, Madison, WI
*Purpose: Evaluate efficacy and safety of a strategy utilizing high dose ganciclovir in kidney and pancreas transplant recipients requiring hospital admission for CMV infection.*Methods: Adult…
2021 American Transplant Congress
Cytomegalovirus Infection Among Adult Kidney Transplant Recipients: Findings From the USRDS-medicare Linked Database Study
A. Raval¹, M. Ganz², S. Alam², Y. Tang¹, C. Santos³
¹Merck & Co., Inc., Rahway, NJ, ²Evidera-PPD, Waltham, MA, ³Rush University Medical Center, Chicago, IL
*Purpose: Cytomegalovirus infection (CMVi) is a frequent complication and significant cause of morbidity and mortality after kidney transplantation (KT). However, there are limited recent national…
2021 American Transplant Congress
Low Immunogenic Donors Improved Survival of Kidney Transplants in African American Recipients
D. Bekbolsynov¹, R. Green², B. Mierzejewska¹, O. Ekwenna¹, M. Rees¹, S. Stepkowski¹
¹University of Toledo, Toledo, OH, ²Bowling Green State University, Bowling Green, OH
*Purpose: Kidney transplants fail more often in African American (AA) than in Caucasian (CAU) recipients. We calculated the hydrophobic mismatch score (HMS) from polymorphic amino…
2021 American Transplant Congress
Days of Delayed Graft Function and Its Impact on Graft Outcomes in Deceased Donor Kidney Transplant
P. Budhiraja¹, R. J. Butterfield², S. S. Misra¹, K. S. Reddy³, L. Kodali¹, H. A. Khamash¹, S. Nair¹, G. K. Mour¹, H. A. Chakkera¹, C. C. Jadlowiec³, H. Janna¹, R. L. Heilman¹
¹Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, ²Department of Statistics, Mayo Clinic Arizona, Phoenix, AZ, ³Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: There has been controversy regarding impact of delayed graft function (DGF) on risk of acute rejection and graft survival. This is likely due to…
2021 American Transplant Congress
Outcomes in Older Recipients Receiving Kidneys from Donors with Acute Kidney Injury (AKI)
S. Nair, K. Reddy, L. Kodali, P. Budhiraja, J. Ninan, C. Jadlowiec, A. Mathur, J. Harbell, H. Khamash, M. Smith, R. Heilman
Mayo Clinic, Phoenix, AZ
*Purpose: Older patients are perceived to tolerate delayed graft function (DGF) poorly and there is a reluctance to transplant a kidney from an AKI donor…
2021 American Transplant Congress
Greater Social Vulnerability is Associated with Self-advocacy in the Living Donor Navigator Program
A. Carter, A. C. Kale, R. D. Reed, B. A. Shelton, H. Qu, M. C. McLeod, B. J. Orandi, R. M. Cannon, D. Anderson, P. MacLennan, V. Kumar, M. Hanaway, J. E. Locke
University of Alabama at Birmingham Hospital, Birmingham, AL
*Purpose: The Living Donor Navigator (LDN) program helps transplant candidates identify live donors by pairing them with an advocate - a friend or family member…
2021 American Transplant Congress
Transplant Decision Making Concerns for Asian Patients with End-Stage Kidney Disease
N. Singh¹, A. Wasim¹, G. Chawla¹, F. Jamil¹, M. Hamid¹, R. Siddiqui¹, E. Lui¹, N. El-Dassouki¹, M. Novak¹, A. D. Waterman², I. Mucsi¹
¹University Health Network, Toronto, ON, Canada, ²David Geffen School of Medicine, UCLA, Los Angeles, CA
*Purpose: Compared to White Canadians, Asian Canadians with end stage kidney disease (ESKD) are less likely to receive living donor kidney transplant (LDKT). We explored…
2021 American Transplant Congress
Predictors of Postoperative Atrial Fibrillation in an Urban, Obese Adult Renal Transplant Population
A. Lichvar, Z. Ress, M. Tabriz, H. Jenkins, T. Walsh, I. Tzvetanov, E. Benedetti, M. Campara
University of Illinois at Chicago, Chicago, IL
*Purpose: Postoperative atrial fibrillation (POAF) is a common surgical complication. Renal transplant (RT) recipients possess risk factors that may lead to a higher incidence of…
2021 American Transplant Congress
Desensitization with Plasmapheresis and IV Immunoglobulin is Safe and Effective in Pra Positive Kidney Transplant Recipient Candidates in Covid-19 Pandemic Period
B. Sayin¹, A. Akdur², E. Karakaya², U. Musabak³, T. Colak¹, M. Haberal²
¹Department of Nephrology, Baskent University, Ankara, Turkey, ²Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey, ³Department of Immunology, Baskent University, Ankara, Turkey
*Purpose: High panel reactive antibody (PRA) levels may limit living-donor kidney transplantation (LDKT) according to increased risk of antibody mediated rejection. Desensitization may provide better…
2021 American Transplant Congress
Avoiding Tacrolimus Under- and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial
M. I. Francke¹, L. M. Andrews², H. L. Le², J. van de Wetering¹, M. C. Clahsen-van Groningen³, T. van Gelder⁴, R. H. van Schaik⁵, B. van der Holt⁶, B. C. de Winter², D. A. Hesselink¹
¹Internal medicine, nephrology and transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ²Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ³Pathology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ⁴Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands, ⁵Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ⁶Hematology, Erasmus MC, University Medical Center, Rotterdam, Netherlands
*Purpose: Bodyweight-based tacrolimus dosing followed by therapeutic drug monitoring is standard clinical care after renal transplantation. However, after transplantation, a meagre 38% of patients is…